Advertisement
Canada markets close in 4 hours 42 minutes

  • S&P/TSX

    21,920.14
    +34.76 (+0.16%)
     

  • S&P 500

    5,096.24
    +47.82 (+0.95%)
     

  • DOW

    38,159.77
    +73.97 (+0.19%)
     

  • CAD/USD

    0.7303
    -0.0020 (-0.28%)
     

  • CRUDE OIL

    83.64
    +0.07 (+0.08%)
     

  • Bitcoin CAD

    87,106.96
    +171.73 (+0.20%)
     

  • CMC Crypto 200

    1,329.17
    -67.36 (-4.83%)
     

  • GOLD FUTURES

    2,346.00
    +3.50 (+0.15%)
     

  • RUSSELL 2000

    1,999.57
    +18.46 (+0.93%)
     

  • 10-Yr Bond

    4.6630
    -0.0430 (-0.91%)
     

  • NASDAQ

    15,914.93
    +303.17 (+1.94%)
     

  • VOLATILITY

    15.28
    -0.09 (-0.59%)
     

  • FTSE

    8,138.91
    +60.05 (+0.74%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Today's Research Reports on CardioComm Solutions, Sernova, Hemostemix and DiaMedica Therapeutics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / October 25, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

CardioComm Solutions, Inc.
https://rdinvesting.com/news/?ticker=EKG.V

Sernova Corp.
https://rdinvesting.com/news/?ticker=SVA.V

Hemostemix Inc.
https://rdinvesting.com/news/?ticker=HEM.V

DiaMedica Therapeutics Inc.
https://rdinvesting.com/news/?ticker=DMA.V

CardioComm Solutions’ stock had no change Wednesday, to close the day at $0.045. The stock recorded a trading volume of 689,076 shares, which was above its three months average volume of 144,871 shares. In the last year, CardioComm Solutions' shares have traded in a range of 0.04 - 0.08. The share price has gained 12.5% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.05 is lower than its 200-day moving average of $0.05.

ADVERTISEMENT

Access RDI's CardioComm Solutions, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EKG.V

On Wednesday, shares of Sernova recorded a trading volume of 144,500 shares, which was below the three months average volume of 159,814 shares. The stock ended the day 5.26% higher at $0.20. The share price has fallen 60.78% from its 52 week high with a 52 week trading range of 0.17 - 0.51. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.20 is lower than its 200-day moving average of $0.25. Shares of Sernova have fallen approximately 52.38 percent year-to-date.

Access RDI's Sernova Corp. Research Report at:
https://rdinvesting.com/news/?ticker=SVA.V

Hemostemix’s stock moved 10.53% lower Wednesday, to close the day at $0.085. The stock recorded a trading volume of 62,000 shares, which was below its three months average volume of 235,490 shares. In the last year, Hemostemix's shares have traded in a range of 0.045 - 0.13. The share price has gained 88.89% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.10 is greater than its 200-day moving average of $0.08. Shares of Hemostemix have gained approximately 21.43 percent year-to-date.

Access RDI's Hemostemix Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HEM.V

On Wednesday, shares of DiaMedica Therapeutics recorded a trading volume of 94,600 shares, which was below the three months average volume of 171,780 shares. The stock ended the day 4.08% lower at $0.47. The share price has fallen 47.78% from its 52 week high with a 52 week trading range of 0.21 - 0.90. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.51 is lower than its 200-day moving average of $0.57. Shares of DiaMedica Therapeutics have gained approximately 62.07 percent year-to-date.

Access RDI's DiaMedica Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMA.V

Our Actionable Research on CardioComm Solutions, Inc. (TSXV:EKG.V), Sernova Corp. (TSXV:SVA.V), Hemostemix Inc. (TSXV:HEM.V) and DiaMedica Therapeutics Inc. (TSXV:DMA.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com